Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D31.90Benign neoplasm of unspecified part of unspecified eye

✓ Billable / specific

D31.90 is a valid, billable ICD-10-CM code for benign neoplasm of unspecified part of unspecified eye. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D31.90

D31.90 is the ICD-10-CM diagnosis code for benign neoplasm of unspecified part of unspecified eye. It belongs to category D31 (benign neoplasm of eye and adnexa), block D10-D36 (benign neoplasms, except benign neuroendocrine tumors) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within D31.9, choose D31.90 (unspecified eye) only when documentation doesn't support a more specific option: right eye (D31.91) and left eye (D31.92).

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent, relative weight 1.2471) and DRG 125 (Other Disorders of the Eye without MCC, relative weight 0.7702), in MDC 02 (Diseases and Disorders of the Eye), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.

Before ICD-10, this condition was coded in ICD-9-CM as 224.8 (benign neoplasm of other specified parts of eye) and 224.9 (benign neoplasm of eye, part unspecified).

Notes that apply from higher levels

Instructions written at a parent level also apply to D31.90.

› From D31 Benign neoplasm of eye and adnexa
Excludes1
  • benign neoplasm of connective tissue of eyelid (D21.0)
  • benign neoplasm of optic nerve (D33.3)
  • benign neoplasm of skin of eyelid (D22.1-, D23.1-)

Broader instructions also apply from Chapter 2: Neoplasms.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

ICD-9-CM equivalent

Converter →
  • 224.8Benign neoplasm of other specified parts of eyeapproximate
  • 224.9Benign neoplasm of eye, part unspecifiedapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
  • No changes since FY2016.

Common questions about D31.90

Is D31.90 billable?

Yes. D31.90 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can D31.90 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict D31.90 as a principal diagnosis.

Is D31.90 a CC or MCC?

No. D31.90 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does D31.90 group to?

D31.90 is used in the MS-DRG v44.0 logic for MS-DRG 124 (Other Disorders of the Eye with MCC or Thrombolytic Agent) and MS-DRG 125 (Other Disorders of the Eye without MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.

What is the ICD-9 code for D31.90?

The CMS General Equivalence Mappings map D31.90 to ICD-9-CM 224.8 and 224.9.